Rooting for Remdesivir; Pharmaceuticals & the Push for Progress

Rooting for Remdesivir; Pharmaceuticals & the Push for Progress

  • Por
  • Episodio
      162
  • Publicado
      17 abr 2020
  • Editorial
0 Calificaciones
0
Episodio
162 of 1789
Duración
21min
Idioma
Inglés
Formato
Categoría
Economía y negocios

Gilead’s experimental Covid-19 treatment caught the markets’ attention after STAT News reported encouraging early results in its phase 3 trial. Former FDA Commissioner Dr. Scott Gottlieb explains the antiviral Remdesivir and explains its potential role in flattening the pandemic’s curve. French pharmaceutical company Sanofi has partnered with peer GlaxoSmithKline to develop a Covid-19 vaccine in the next 18 months. Sanofi has also partnered with a startup to create a coronavirus test using a smartphone. CEO Paul Hudson explains the news, the technology, and the path ahead for a healthier planet.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


Escucha y lee

Descubre un mundo infinito de historias

  • Lee y escucha todo lo que quieras
  • Más de 1 millón de títulos
  • Títulos exclusivos + Storytel Originals
  • Precio regular: CLP 7,990 al mes
  • Cancela cuando quieras
Copy of Device Banner Block 894x1036 3
Cover for Rooting for Remdesivir; Pharmaceuticals & the Push for Progress

Otros podcasts que te pueden gustar...